MX9602943A - Formulacion acuosa de liberacion prolongada. - Google Patents
Formulacion acuosa de liberacion prolongada.Info
- Publication number
- MX9602943A MX9602943A MX9602943A MX9602943A MX9602943A MX 9602943 A MX9602943 A MX 9602943A MX 9602943 A MX9602943 A MX 9602943A MX 9602943 A MX9602943 A MX 9602943A MX 9602943 A MX9602943 A MX 9602943A
- Authority
- MX
- Mexico
- Prior art keywords
- bovine somatotropin
- aqueous
- release formulation
- prolonged release
- circulatory system
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 108010006025 bovine growth hormone Proteins 0.000 abstract 4
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La liberacion prolongada en el sistema circulatorio de una vaca, por medio de la administracion parenteral de una somatotropina bovina biologicamente activa, en niveles deseablemente efectivos, se puede lograr usando composiciones nuevas, en las cuales la somatotropina bovina está presente en un líquido acuoso en una dosificacion de, por lo menos aproximadamente 150 mg y en una concentracion de por lo menos aproximadamente 50 mg/ml. La formulacion acuosa de la somatotropina bovina proporciona la liberacion sostenida de la somatotropina bovina, en el sistema circulatorio del animal pro períodos mayores a tres (3) días.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18657294A | 1994-01-25 | 1994-01-25 | |
| PCT/US1995/000023 WO1995019787A1 (en) | 1994-01-25 | 1995-01-09 | Aqueous prolonged release formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9602943A true MX9602943A (es) | 1997-06-28 |
Family
ID=22685468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9602943A MX9602943A (es) | 1994-01-25 | 1995-01-09 | Formulacion acuosa de liberacion prolongada. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6471977B1 (es) |
| EP (1) | EP0741579B1 (es) |
| JP (1) | JPH09508118A (es) |
| KR (1) | KR100355517B1 (es) |
| CN (1) | CN1139385A (es) |
| AT (1) | ATE187077T1 (es) |
| AU (1) | AU699746B2 (es) |
| CA (1) | CA2178610A1 (es) |
| DE (1) | DE69513635T2 (es) |
| DK (1) | DK0741579T3 (es) |
| ES (1) | ES2139881T3 (es) |
| GR (1) | GR3032727T3 (es) |
| LV (1) | LV12627B (es) |
| MX (1) | MX9602943A (es) |
| NZ (1) | NZ278770A (es) |
| SI (1) | SI0741579T1 (es) |
| WO (1) | WO1995019787A1 (es) |
| ZA (1) | ZA949350B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA949350B (en) * | 1994-01-25 | 1996-05-24 | Upjohn Co | Aqueous prolonged release formulation |
| CA2240685A1 (en) | 1996-01-11 | 1997-07-17 | Pharmacia & Upjohn Company | Aqueous prolonged release formulation |
| US7319032B2 (en) * | 2004-04-22 | 2008-01-15 | Medtox | Non-sugar sweeteners for use in test devices |
| LT4037666T (lt) | 2020-12-08 | 2024-06-10 | Ruminant Biotech Corp Limited | Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4118380A (en) | 1977-07-25 | 1978-10-03 | Ayerst, Mckenna & Harrison Limited | Decapeptide analogs of somatostatin |
| EP0140255B1 (en) | 1983-10-14 | 1991-05-15 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release injections |
| US4774091A (en) | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
| US4985404A (en) | 1984-10-04 | 1991-01-15 | Monsanto Company | Prolonged release of biologically active polypeptides |
| KR890002631B1 (ko) | 1984-10-04 | 1989-07-21 | 몬산토 캄파니 | 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물 |
| EP0193917A3 (en) | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
| IL79552A0 (en) * | 1985-07-30 | 1986-10-31 | Int Minerals & Chem Corp | Stabilization of growth promoting hormones |
| US4977140A (en) | 1985-08-23 | 1990-12-11 | Eli Lilly And Company | Injectable sustained release formulation |
| US4816568A (en) | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
| US4857506A (en) | 1987-01-12 | 1989-08-15 | American Cyanamid Company | Sustained release growth hormone compositions for parenteral administration and their use |
| US4863736A (en) | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
| US4888416A (en) | 1987-03-30 | 1989-12-19 | International Minerals & Chemical Corp. | Method for stabilizing somatotropins |
| ATE130195T1 (de) | 1988-07-26 | 1995-12-15 | Univ Rutgers | Vorrichtungen und verfahren zur wachstumsförderung bei bratgeflügel. |
| EP0374120A3 (en) | 1988-12-13 | 1991-07-31 | Monsanto Company | Comosition for controlled release of polypeptides |
| US5015627A (en) | 1990-07-20 | 1991-05-14 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
| US5169834A (en) | 1990-11-30 | 1992-12-08 | American Cyanamid Company | Compositions and method for reducing vial breakage during lyophilization |
| US5198422A (en) | 1992-06-11 | 1993-03-30 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
| ZA949350B (en) * | 1994-01-25 | 1996-05-24 | Upjohn Co | Aqueous prolonged release formulation |
-
1994
- 1994-11-24 ZA ZA949350A patent/ZA949350B/xx unknown
-
1995
- 1995-01-09 AU AU15213/95A patent/AU699746B2/en not_active Ceased
- 1995-01-09 CN CN95191312A patent/CN1139385A/zh active Pending
- 1995-01-09 JP JP7519567A patent/JPH09508118A/ja not_active Ceased
- 1995-01-09 SI SI9530361T patent/SI0741579T1/xx unknown
- 1995-01-09 MX MX9602943A patent/MX9602943A/es not_active IP Right Cessation
- 1995-01-09 EP EP95906743A patent/EP0741579B1/en not_active Expired - Lifetime
- 1995-01-09 DE DE69513635T patent/DE69513635T2/de not_active Expired - Fee Related
- 1995-01-09 DK DK95906743T patent/DK0741579T3/da active
- 1995-01-09 KR KR1019960703998A patent/KR100355517B1/ko not_active IP Right Cessation
- 1995-01-09 US US08/696,985 patent/US6471977B1/en not_active Expired - Fee Related
- 1995-01-09 ES ES95906743T patent/ES2139881T3/es not_active Expired - Lifetime
- 1995-01-09 CA CA002178610A patent/CA2178610A1/en not_active Abandoned
- 1995-01-09 NZ NZ278770A patent/NZ278770A/en unknown
- 1995-01-09 AT AT95906743T patent/ATE187077T1/de not_active IP Right Cessation
- 1995-01-09 WO PCT/US1995/000023 patent/WO1995019787A1/en active IP Right Grant
-
2000
- 2000-02-23 GR GR20000400426T patent/GR3032727T3/el not_active IP Right Cessation
- 2000-12-01 LV LVP-00-165A patent/LV12627B/en unknown
-
2002
- 2002-09-16 US US10/244,726 patent/US6699490B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09508118A (ja) | 1997-08-19 |
| CA2178610A1 (en) | 1995-07-27 |
| EP0741579A1 (en) | 1996-11-13 |
| DE69513635T2 (de) | 2000-05-31 |
| EP0741579B1 (en) | 1999-12-01 |
| CN1139385A (zh) | 1997-01-01 |
| LV12627B (en) | 2001-08-20 |
| ZA949350B (en) | 1996-05-24 |
| US20030092625A1 (en) | 2003-05-15 |
| DK0741579T3 (da) | 2000-05-15 |
| US20030220242A9 (en) | 2003-11-27 |
| KR100355517B1 (ko) | 2003-03-04 |
| ES2139881T3 (es) | 2000-02-16 |
| NZ278770A (en) | 1997-09-22 |
| US6699490B2 (en) | 2004-03-02 |
| US6471977B1 (en) | 2002-10-29 |
| AU1521395A (en) | 1995-08-08 |
| SI0741579T1 (en) | 2000-04-30 |
| ATE187077T1 (de) | 1999-12-15 |
| DE69513635D1 (de) | 2000-01-05 |
| WO1995019787A1 (en) | 1995-07-27 |
| GR3032727T3 (en) | 2000-06-30 |
| AU699746B2 (en) | 1998-12-10 |
| LV12627A (lv) | 2001-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0783299A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES | |
| NZ294464A (en) | Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products | |
| MY125556A (en) | Aqueous formulations of peptide | |
| IL109403A0 (en) | Oral drug delivery compositions and methods | |
| FI970298A0 (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
| IL89276A0 (en) | Human relaxin formulation | |
| HUT66429A (en) | Compositions for treating osteoporosis | |
| TW264386B (es) | ||
| ES2100354T3 (es) | Sistema de implante nervioso. | |
| HK1016083A1 (en) | Aqueous prolonged release formulation | |
| ZA949350B (en) | Aqueous prolonged release formulation | |
| EP0572494A4 (en) | Composition for use in transdermal administration | |
| GR3029319T3 (en) | Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity | |
| GB8603964D0 (en) | Compositions | |
| ES8800040A1 (es) | Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. | |
| GR3032546T3 (en) | Use of azoles as virucidal agents in solutions of biologically active proteins | |
| EP0539516A4 (es) | ||
| IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
| IL95059A0 (en) | Composition for administration of nitrofurantoin | |
| MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. | |
| BG49848A1 (en) | Cytocinine means |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |